Emotionality enhancement

Emotionality enhancement can be described as an effect which amplifies and enhances one's current emotional state beyond normal levels.

Unlike many other subjective effects such as euphoria or anxiety this effect does not consistently induce specific emotions regardless of a person's current state of mind and mental stability. Instead, it works by amplifying and enhancing the genuine emotions that a person is already feeling prior to ingesting the drug. This causes the effects to be equally capable of manifesting in both a positive and negative direction.

For example, an individual who is currently feeling somewhat anxious or emotionally unstable may become overwhelmed with intensified negative emotions, paranoia, and confusion. In contrast, an individual who is generally feeling positive and emotionally stable is more likely to find themselves overwhelmed with states of emotional euphoria, happiness, and feelings of general contentment.

This effect is commonly triggered by psychedelic compounds such as LSD, psilocin, and mescaline. However, it can occassionally occur under the influence of other compounds such as cannabis and stimulant entactogens.

psychoactive substances

Compounds which may cause this effect commonly include:

1P-ETH-LAD, 1P-LSD, 25B-NBOH, 25B-NBOMe, 25C-NBOH, 25C-NBOMe, 25D-NBOMe, 25I-NBOH, 25I-NBOMe, 25N-NBOMe, 2C-B, 2C-B-FLY, 2C-C, 2C-D, 2C-E, 2C-I, 2C-P, 2C-T-2, 2C-T-7, 3C-E, 4-AcO-DET, 4-AcO-DMT, 4-AcO-MET, 4-AcO-MiPT, 4-HO-DPT, 4-HO-DiPT, 4-HO-EPT, 4-HO-MPT, 4-HO-MiPT, 5-MeO-DALT, 5-MeO-DMT, 5-MeO-DiBF, 5-MeO-DiPT, 5-MeO-MiPT, 5F-AKB48, 5F-PB-22, 6-APB, AB-CHMINACA, AB-FUBINACA, AL-LAD, ALD-52, APICA, Adrafinil, Allylescaline, Ayahuasca, Bk-2C-B, Bromo-DragonFLY, Bufotenin, Cannabis, DET, DMT, DOB, DOC, DOI, DOM, DPT, Dehydroxyfluorafinil, Dextromethorphan, Ibogaine, JWH-018, JWH-073, LSA, LSD, LSZ, MDA, MDMA, MET, MPT, Mescaline, Methallylescaline, MiPT, Modafinil, Proscaline, Psilocin, Psilocybin mushrooms, STS-135, THJ-018, THJ-2201, TMA-2, TMA-6, ΑMT

See also


Documentation written by Josie Kins